drugset / Trial / NCT00679315
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
Phase 2
Completed
190 enrolled
Samsung Medical Center
Handok Inc. · collabThe Korean Urological Association · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to explore the efficacy of Alfuzosin (10 mg, qd) in reducing the score of International Prostate Symptom Score (IPSS) from baseline to 8 weeks of treatment in female patients with voiding dysfunction.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-03
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfuzosin | Small molecule | 10 mg | — |